A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander Kolevzon, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Bryan King, MD
Seattle Children's Hospital
Principal Investigator - Craig Erickson, MD
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Diane Treadwell-Deering, MD
Baylor College of Medicine
Principal Investigator - Elizabeth M Berry-Kravis, MD
Rush University Medical Center
Principal Investigator - Howard Needleman, MD
University of Nebraska
Principal Investigator - Jean Frazier, MD
University of Massachusetts, Worcester
Principal Investigator - Jeffrey Innis, MD
University of Michigan
Principal Investigator - Joseph Cubells, MD, PhD
Emory University
Principal Investigator - Kevin Sanders, MD
Vanderbilt University Medical Center
Principal Investigator - Nicole Tartaglia, MD
Children's Hospital Colorado
Principal Investigator - Randi Hagerman, MD
UC Davis MIND Institute
Principal Investigator - Robert Findling, MD
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Principal InvestigatorKOL profile → - Shivkumar Hatti, MD
Suburban Research Associates
Principal Investigator - Steve Skinner, MD
Greenwood Genetic Center
Principal Investigator - Thomas Challman, MD
Autism & Developmental Medicine Institute Geisinger Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc Davis Mind Institute
Sacramento, California, United States
- Children'S Hospital Colorado
Denver, Colorado, United States
- Children'S National Hospital
Washington D.C., District of Columbia, United States
- Emory University
Atlanta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Kennedy Krieger Institute
Baltimore, Maryland, United States
- University of Massachusetts Medical School
Worcester, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Nebraska
Omaha, Nebraska, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Autism & Developmental Medicine Institute Geisinger Health System
Lewisburg, Pennsylvania, United States
- Suburban Research Associates
Media, Pennsylvania, United States
- Greenwood Genetic Center
Greenwood, South Carolina, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2014
- Primary completion
- 30 Sept 2015
- Completion
- 31 Oct 2015
- Last update posted
- 5 Feb 2018
- Registered enrollment
- 72
- Registry id
- NCT01894958
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.